Riskpilot← Back to searchSign inGet full accessFirstDoc Dalarna AB
ABActiveOrg 5592178817Plankstigen 9General medical practice activities · NACE 8621Est. 20192 employees
Revenue 2025
SEK 662K
-70% vs 2024
EBITDA margin
21.5%
-72% vs 2024
Equity ratio
69.2%
Financial strength
Net profit 2025
SEK 116K
-71% vs 2024
| Revenue | SEK 662K | -70% |
| EBITDA | SEK 143K | -72% |
| Net profit | SEK 116K | -71% |
| Total assets | SEK 453K | -51% |
| Equity | SEK 314K | -43% |
| Employees | 2 | — |
Legal name
FirstDoc Dalarna AB
Org number
5592178817
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
10 september 2019
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Utfärdande av medicinska intyg. Konsult och föreläsningar inom allmänmedicin. Hälsoundersökningar, vaccinationer och injektioner. Översättning av dokument och media.
Address
Plankstigen 9
Email
martin.a.mckeon@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 321 | 745 | 1 693 | 2 201 | 662 |
| Staff expenses | — | −373 | −935 | −1 520 | −260 |
| EBITDA | 132 | 277 | 589 | 504 | 143 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 132 | 277 | 589 | 504 | 143 |
| Net financials | −1 | 0 | 1 | 3 | 4 |
| Profit before tax | 131 | 277 | 590 | 508 | 147 |
| Tax | −27 | −57 | −121 | −104 | −31 |
| Net profit | 104 | 220 | 468 | 404 | 116 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 264 | 451 | 1 038 | 922 | 453 |
| Equity | 156 | 276 | 544 | 548 | 314 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 108 | 175 | 494 | 374 | 140 |
| Total debt | 108 | 175 | 494 | 374 | 140 |
EBITDA margin
21.5%
This company
15.8%
Market median
+36% vs market
20212025
Equity ratio
69.2%
This company
38.2%
Market median
+81% vs market
20212025
Return on equity
36.9%
This company
18.4%
Market median
+101% vs market
20212025
Net profit margin
17.5%
This company
8.1%
Market median
+116% vs market
20212025
Asset turnover
1.46×
This company
1.12×
Market median
+30% vs market
20212025
Debt / equity
0.45×
This company
0.62×
Market median
+27% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FirstDoc Dalarna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Mc Keon | Chairman | 0 companies |
| Jim Mc Keon | Deputy Board Member | 0 companies |
| Anna Margareta Mc Keon | Board of Directors | 0 companies |